Cite

HARVARD Citation

    Cui, X. et al. (2018). Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response. Vaccine. 36 (37), pp. 5580-5590. [Online]. 
  
Back to record